Lotus Bakeries N.V. (0F4O)
London Stock Exchange · UK · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 13,340.00 |
|---|---|
| 52-week range | 7,270.00 – 13,500.00 |
| Return, 1 month / 3 months | +6.5% / +24.9% |
| Return, 1 year / 3 years | +65.9% / +96.3% |
| Trend | Uptrend |
| RSI (14) | 68 |
| Volatility (1 year) | 26.0% |
| Worst drawdown (1 year) | -11.7% |
| Average daily value traded | 1.28M EUR |
| Dividend yield | 0.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lotus Bakeries is a Belgian food company based in Lembeke that makes caramelised biscuits sold under the Biscoff name, along with speculoos spreads and related sweet treats. It also produces snack bars and other baked goods through brands such as Nakd and Trek. Its customers are grocery retailers, food service operators and consumers in many countries, who buy its biscuits and spreads for everyday snacking and baking.
The shares are listed on the London Stock Exchange in UK under the code 0F4O, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lotus Bakeries N.V. (0F4O) trades on the London Stock Exchange in UK. It last closed at EUR 13,340.00 on 27 October 2026.
Its price-based Market X-Ray is 77 out of 100 (a strong price profile), ranking 181 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 65.9% and over the last three months it rose 24.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 20.5% | ||
| From 52-week high | 0.0% | ||
| Momentum | 90 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 24.9% | ||
| 6-month return | 32.9% | ||
| 12-month return, skipping the last month | 55.7% | ||
| Stability (higher is calmer) | 83 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 26.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -11.7% | ||
| Liquidity | 56 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.28M EUR | ||
| Zero-volume days | 6.7% | ||
| Income | 24 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.5% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.2% |
|---|---|
| 1 month | +6.5% |
| 3 months | +24.9% |
| 6 months | +32.9% |
| 1 year | +65.9% |
| 3 years | +96.3% |
| 5 years | +133.7% |
Signals
| 50-day / 200-day average | 12,544.40 / 11,069.25 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 268.28 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 May 2026 | EUR 63.0000 |
| 15 May 2025 | EUR 53.2000 |
| 16 May 2024 | EUR 40.6000 |
| 16 May 2023 | EUR 31.5000 |
| 16 May 2022 | EUR 28.0000 |
| 20 May 2021 | EUR 24.8500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.